Maori Direct Investment Fund Gets a Stake in Asia Pacific Health Group Posted on 02/04/2021 Asia Pacific Health Group (APHG) is New Zealand’s largest human and veterinary pathology network operating as Labtests Auckland, Northland Pathology, Taranaki Pathology Services, Southern Community Laboratories, Wellington SCL, Canterbury SCL, Medlab South & Gribbles Veterinary Pathology. With 25 laboratories, over 2,000 staff and 150 collection centres throughout NZ, APHG performs over 6.7 million pathology patient episodes annually across New Zealand. The Te Pūia Tāpapa Investment Fund is made up of 28 Iwi and Māori entities. Its investors represent diversity of scale and geography comprising Iwi and Māori entities located in Te Tau Ihu (Nelson-Marlborough), lower and central North Island, Taranaki, Waikato, Bay of Plenty, Hauraki, Northland, Auckland and Wharekauri (Chatham Islands). The Te Pūia Tāpapa investment approach reflects the Māori long term world view, with generational investment periods of 15-20 years. Te Pūia Tāpapa is a preferred partner of NZ Super Fund and seeks similar partnerships with other highly regarded investors.